Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours

British Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 632-637

  Nilsson, O ^a   Kolby L ^a   Wangberg B ^a   Wigander, A ^a   Billig, H ^a   William Olsson, L ^a   Fjalling M ^a   Forssell Aronsson, E ^a   Ahlman, H ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carcinoid tumours; Octreotide; Somatostatin receptors

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; INDIUM 111; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CARCINOID; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDGUT; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031964239     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.101     Document Type: Article

References (25)

1. Ahlman H, Tisell LE, Wüngberg B, Fjälling M, Forssell-Aronsson E, Kölby L and Nilsson O (1997) The relevance of somatostatin receptors in thyroid neoplasia. Yale J Biol Med (in press)
2. Ahlman H, Wängberg B, Tisell LE, Nilsson O, Fjälling M and Forssell-Aronsson E (1994) Clinical efficacy of octreotide scintigraphy in patients wilh midgut carcinoid tumours and evaluation of intraoperative scintillation detection. Br J Surg 81: 1144-1149
3. 1-octreotide. J Nucl Med 37: 2002-2006
4. Arnold R, Trautmann ME, Creutzfeldt W, Benning R, Benning M, Neuhaus C, Jürgensen R, Stein K, Schäfer H, Bruns C and Dennler HJ (1996) Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38: 430-438
5. 1-octreolide for detection of somatostatin receptor-positive tumours in rats. Life Sci 49: 1593-1601
6. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D and Lübbert H (1994) Molecular pharmacology of somatostatin-receptor subtypes. Ann N Y Acad Sci 733: 138-146
7. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
8. Evers BM, Townsend CM, Jr, Upp JR, Allen E, Hurlbut SC, Kim SW, Rajaraman S, Singh P, Reubi JC and Thompson JC (1991) Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumour growth. Gastroenterology 101: 303-311
9. Fjälling M, Andersson P, Forssell-Aronsson E, Grétarsdóttir J, Johanson V, Tisell LE, Wängberg B, Nilsson O, Berg G, Michanek A, Lindstedt, G and Ahlman H (1996) Systemic radionuclide therapy using Indium-111-DTPA-D-Phe 1-octreotide in midgut carcinoid syndrome. J Nucl Med 37: 1519-1521
10. Forssell-Aronsson E, Fjälling M, Nilsson O, Tisell LE, Wängberg B and Ahlman H (1995) Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. J Nucl Med 36: 7-12
11. Gordon P, Comi RJ, Maton PN and Go VL (1989) NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone secreting tumours of the pituitary and gastrointestinal tract and non-neoplastic disease of the gut. Ann Intern Med 110: 35-50
12. John M, Meyerhof W, Richter D, Waser B, Schaer JC, Scherübl H, Boese-Landgraf J, Neuhaus P, Ziske C, Mölling K, Riecken EO, Reubi JC and Wiedenmann B (1996) Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut 38: 33-39
13. Krenning EP, Kooij PPM, Pauwels S, Breeman WAP, Postema PTE, De Herder WW, Valkema R and Kwekkeboom DJ (1996) Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion 57: 57-61
14. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S and Seino Y (1994) Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93: 1321-1325
15. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J and Hahn RG (1986) Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 315: 663-666
16. Nilsson O, Wängberg B, Theodorsson E, Skottner A and Ahlman H (1992) Presence of IGh-1 in human midgut carcinoid tumours - an autocrine regulator of carcinoid tumour growth? Int J Cancer 51: 195-203
17. Patel YC and Srikant CB (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135: 2814-2817
18. Raulf F, Pérez J, Hoyer D and Bruns C (1994) Differential expression of five somatostatin receptor subtypes. SSTR1-5, in the CNS and peripheral tissue. Digestion 55 (suppl. 3): 46-53
19. Reubi JC, Häcki WH and Lamberts SW (1987) Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 65: 1127-1134
20. Reubi JC, Krenning E, Lamberts SW and Kvols L (1990) Somatostatin receptors in malignant tissues. J Steroid Biochem Mol Biol 37: 1073-1077
21. Saltz L, Trochanowski B, Buckley M, Heffernan B, Niedzwiecki D, Tao Y and Kelsen D (1993) Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer 72: 244-248
22. Tisell LE, Ahlman H, Wängberg B, Hansson G, Mölne J, Nilsson O, Lindstedt G, Fjälling M and Forssell-Aronsson E (1997) Somatostatin receptor scintigraphy in medullary thyroid carcinoma. Br J Surg 84: 543-547
23. 1-octreotide. Br J Cancer 73: 770-775
24. Wängberg B, Nilsson O, Theodorsson E, Dahlström A and Ahlman H (1991) The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells. Br J Cancer 64: 23-28
25. Westberg G, Ahlman H, Nilsson O, Illerskog A and Wängberg B (1997) Secretory patterns of tryptophan metabolites in midgut carcinoid tumor cells. Neurochem Res 22: 977-983